Nutra Pharma Corp., a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has today announced that it has partnered with the European Union-based World AIDS Campaign to help raise awareness about global AIDS initiatives aimed at eradicating the disease by 2015.

“We are pleased to announce our partnership with the World AIDS Campaign,” commented Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. “This organization serves an important role in the global AIDS community and we are proud to be one of the United States partners,” he added.

The World AIDS Campaign aims to ensure that AIDS leaders and decision makers keep their promises on AIDS. Driven by a range of global AIDS networks, it campaigns on AIDS both locally and internationally. The campaign brings together faith, labour, youth, women, positive networks, NGOs and other constituencies within common advocacy and mobilisation efforts.

SEC Disclaimer

This press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in Nutra Pharma's ("the Company") business plan. The Company's business is subject to various risks, which are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"). The partnership with the World AIDS Campaign should not be construed as an indication in any way whatsoever of the value of the Company or its common stock. The Company's filings may be accessed at the SEC's Edgar system at www.sec.gov. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.